|Mr. McCord Christensen||Chairman & CEO||N/A||N/A||1972|
|Ms. Susan Sholtis||Pres||181.15k||N/A||1966|
|Mr. John Newland||Chief Financial Officer||N/A||N/A||1964|
|Mr. Robert Michael Herrman||Gen. Counsel & Sec.||N/A||N/A||N/A|
|Mr. Adam Fellers||Sr. VP of Sales||N/A||N/A||N/A|
PetIQ, Inc. operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers Rx pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and OTC medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company offers its products primarily under the PetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 39 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. As of May 21, 2019, it operated through approximately 60,000 points of distribution across retail and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
PetIQ, Inc.’s ISS Governance QualityScore as of June 25, 2019 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 8; Compensation: 8.